Similar articles

• The role of a protective environment and prophylactic granulocyte transfusion in marrow transplantation.

  Buckner CD, Clift RA, Sanders JE, Thomas ED. Buckner CD, et al. Transplant Proc. 1978 Mar;10(1):255-7. Transplant Proc. 1978. PMID: 345564 No abstract available.
• CMV prophylaxis in allogeneic BMT with ganciclovir and CMV immune globulin.

  Patton WN, Carter C, Bienz N, Lamb T, Boughton BJ, Franklin IM. Patton WN, et al. Bone Marrow Transplant. 1991;7 Suppl 2:44. Bone Marrow Transplant. 1991. PMID: 1652330 Clinical Trial. No abstract available.
• Prophylactic use of immunoglobulin in bone marrow transplantation.

  Ho WG, Winston DJ, Champlin RE, Gale RP. Ho WG, et al. Int J Cell Cloning. 1986;4 Suppl 1:174-80. doi: 10.1002/stem.5530040717. Int J Cell Cloning. 1986. PMID: 3018101 No abstract available.
• Prevention of cytomegalovirus infection in bone marrow transplant recipients by prophylaxis with an intravenous, hyperimmune cytomegalovirus globulin.

  Condie RM, O'Reilly RJ. Condie RM, et al. Birth Defects Orig Artic Ser. 1984;20(1):327-44. Birth Defects Orig Artic Ser. 1984. PMID: 6329370 Review. No abstract available.
• Infections in bone marrow transplant recipients.

  van der Meer JW, Guiot HF, van den Broek PJ, van Furth R. van der Meer JW, et al. Semin Hematol. 1984 Apr;21(2):123-40. Semin Hematol. 1984. PMID: 6204385 Review. No abstract available.